Hyper-expensive new therapies and the prioritisation of R&D (original) (raw)
Related papers
Hyper-expensive Treatments: Background paper
Ethics roundtable: Using new, expensive drugs
Critical care (London, England), 2002
Concise Review: The High Cost of High Tech Medicine: Planning Ahead for Market Access
Stem cells translational medicine, 2017
Treatment Is Worth a Lot - But Just How Much
Biomedicine Hub, 2017
Medical paternalism and expensive unsubsidised drugs
Access to high cost medicines in Australia: ethical perspectives
Australia and New Zealand Health Policy, 2008
A pill too hard to swallow: how the NHS is limiting access to high priced drugs
BMJ, 2016
Ethics of clinical trials: the ‘forbidden fruit’ phenomena
Breast, 1996
Fair Pricing of Innovative Medicines: An EHA Position Paper
HemaSphere, 2020
Propelling Healthcare with Advanced Therapy Medicinal Products: A Policy Discussion
Biomedicine Hub
How Should Therapeutic Decisions about Expensive Drugs Be Made in Imperfect Environments?
AMA journal of ethics, 2017
Ethical Perspectives on Costly Drugs and Health Care
Neurology, 2021
Clinical and Ethical Perspectives on Rationing of High-Cost Drugs
Annals of Pharmacotherapy, 1995
A human rights-based approach to the reimbursement of expensive medicines
Bulletin of the World Health Organization, 2016
Regulating innovative treatments: information, risk allocation and redress
Law, Innovation and Technology
The Bio-Economy: A Challenge to the Integrity of Medicine and Healthcare
Asian Bioethics Review, 2014
2008
JAMA Otolaryngology–Head & Neck Surgery, 2014
Just caring: Assessing the ethical and economic costs of personalized medicine
Urologic Oncology: Seminars and Original Investigations, 2014
Fair funding of extraordinarily expensive medication
Bioethica Forum, 2011
Frontiers in Public Health
Pharmacoeconomics, 2008
The legal imperative for treating rare disorders
Orphanet Journal of Rare Diseases, 2013
Cancer medicines: a private vice for public benefit
eCancer, 2024